Is CyberArk The Next Big Cybersecurity Stock?
CyberArk Software (NASDAQ: CYBR) recently reported phenomenal quarter numbers, passing…
Sell
40
REZI Quote, Financials, Valuation and Earnings
Last price:
$17.44
Seasonality move
:
1.44%
Day range:
$17.42 - $17.84
52-week range:
$16.88 - $28.28
Dividend yield:
0%
P/E ratio:
28.08x
P/S ratio:
0.39x
P/B ratio:
0.93x
Volume:
832.6K
Avg. volume:
1.1M
1-year change:
-21.93%
Market cap:
$2.6B
Revenue:
$6.8B
EPS (TTM):
$0.63
Resideo Technologies Number of Institutional Trades
Resideo Technologies Volume of Institutional Trades
Amount of Institutions Buying
--
(Last Month)
Amount of Institutional Buying
$6.7B
(Last 6 Months)
Current Institutional Ownership Percentage
--
Amount of Institutions Selling
--
(Last Month)
Amount of Institutional Selling
$2.6B
(Last 6 Months)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Resideo Technologies Institutional Ownership
-
What Percentage Of REZI Is Owned by Institutions?
-- of REZI is owned by institutions.
-
How Many Institutions Own REZI Shares?
Resideo Technologies stock is owned by 739 institutional shareholders at this time.
-
Have Institutions Been Buying REZI Stock?
Yes, institutions have bought 187.6M shares of REZI in the last quarter.
-
Have Institutions Been Selling REZI Stock?
Yes, institutions have sold 64.1M shares of REZI over the last quarter.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is the Market Going to Go Lower?
The last month has been extremely difficult for the stock…
2 Dividend Stocks to Buy in a Recession
While many economists and investors initially expected 2025 to be…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
54
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 41x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Alerts
Buy
52
RGC alert for Mar 18
Regencell Bioscience Holdings [RGC] is up 73.51% over the past day.
Buy
63
EXOD alert for Mar 18
Exodus Movement [EXOD] is down 3.96% over the past day.
Sell
45
MNPR alert for Mar 18
Monopar Therapeutics [MNPR] is up 0.93% over the past day.
